Search research articles
Contact Us
Filters
Showing results (81-90 of 100) with videos related to
Page
of 10
Sort By:
ACS Medicinal Chemistry Letters
|
June 6, 2014
Potent Targeting of the STAT3 Protein in Brain Cancer Stem Cells: A Promising Route for Treating Glioblastoma
Sina Haftchenary, H Artee Luchman, Andriana O Jouk, et al.
Chemmedchem
|
March 31, 2016
Disarming an Electrophilic Warhead: Retaining Potency in Tyrosine Kinase Inhibitor (TKI)-Resistant CML Lines While Circumventing Pharmacokinetic Liabilities
Ahmed M Ali, Rodolfo F Gómez-Biagi, David A Rosa, et al.
Science Signaling
|
April 24, 2014
Dynamic reprogramming of signaling upon met inhibition reveals a mechanism of drug resistance in gastric cancer
Andrea Z Lai, Sean Cory, Hong Zhao, et al.
Leukemia
|
February 24, 2018
Pharmacologic inhibition of STAT5 in acute myeloid leukemia
Bettina Wingelhofer, Barbara Maurer, Elizabeth C Heyes, et al.
Cancers
|
April 25, 2020
STAT5 is Expressed in CD34<sup>+</sup>/CD38<sup>-</sup> Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms
Emir Hadzijusufovic, Alexandra Keller, Daniela Berger, et al.
Journal of Medicinal Chemistry
|
February 12, 2021
Unique Molecular Interaction with the Histone Deacetylase 6 Catalytic Tunnel: Crystallographic and Biological Characterization of a Model Chemotype
Olasunkanmi O Olaoye, Paris R Watson, Nabanita Nawar, et al.
Journal of Medicinal Chemistry
|
February 19, 2019
Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Orthotopic Mouse Model of Pancreatic Cancer
Andrew E Shouksmith, Fenil Shah, Michelle L Grimard, et al.
Molecular Cancer Therapeutics
|
February 14, 2016
Applying Small Molecule Signal Transducer and Activator of Transcription-3 (STAT3) Protein Inhibitors as Pancreatic Cancer Therapeutics
Carolyn C Arpin, Stephen Mac, Yanlin Jiang, et al.
Journal of Medicinal Chemistry
|
February 4, 2022
Discovery of HDAC6-Selective Inhibitor NN-390 with <i>in Vitro</i> Efficacy in Group 3 Medulloblastoma
Nabanita Nawar, Shazreh Bukhari, Ashley A Adile, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Acetylation of Axonal G3BP1 through ELP3 Accelerates Axon Regeneration
Irene Dalla Costa, Emily Michenfelder, Sophia Siciliano, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 100) with videos related to
Sort By:
Page
of 10
ACS Medicinal Chemistry Letters
|
June 6, 2014
Potent Targeting of the STAT3 Protein in Brain Cancer Stem Cells: A Promising Route for Treating Glioblastoma
Sina Haftchenary, H Artee Luchman, Andriana O Jouk, et al.
Chemmedchem
|
March 31, 2016
Disarming an Electrophilic Warhead: Retaining Potency in Tyrosine Kinase Inhibitor (TKI)-Resistant CML Lines While Circumventing Pharmacokinetic Liabilities
Ahmed M Ali, Rodolfo F Gómez-Biagi, David A Rosa, et al.
Science Signaling
|
April 24, 2014
Dynamic reprogramming of signaling upon met inhibition reveals a mechanism of drug resistance in gastric cancer
Andrea Z Lai, Sean Cory, Hong Zhao, et al.
Leukemia
|
February 24, 2018
Pharmacologic inhibition of STAT5 in acute myeloid leukemia
Bettina Wingelhofer, Barbara Maurer, Elizabeth C Heyes, et al.
Cancers
|
April 25, 2020
STAT5 is Expressed in CD34<sup>+</sup>/CD38<sup>-</sup> Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms
Emir Hadzijusufovic, Alexandra Keller, Daniela Berger, et al.
Journal of Medicinal Chemistry
|
February 12, 2021
Unique Molecular Interaction with the Histone Deacetylase 6 Catalytic Tunnel: Crystallographic and Biological Characterization of a Model Chemotype
Olasunkanmi O Olaoye, Paris R Watson, Nabanita Nawar, et al.
Journal of Medicinal Chemistry
|
February 19, 2019
Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Orthotopic Mouse Model of Pancreatic Cancer
Andrew E Shouksmith, Fenil Shah, Michelle L Grimard, et al.
Molecular Cancer Therapeutics
|
February 14, 2016
Applying Small Molecule Signal Transducer and Activator of Transcription-3 (STAT3) Protein Inhibitors as Pancreatic Cancer Therapeutics
Carolyn C Arpin, Stephen Mac, Yanlin Jiang, et al.
Journal of Medicinal Chemistry
|
February 4, 2022
Discovery of HDAC6-Selective Inhibitor NN-390 with <i>in Vitro</i> Efficacy in Group 3 Medulloblastoma
Nabanita Nawar, Shazreh Bukhari, Ashley A Adile, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Acetylation of Axonal G3BP1 through ELP3 Accelerates Axon Regeneration
Irene Dalla Costa, Emily Michenfelder, Sophia Siciliano, et al.
Page
of 10